Posted 22 March, 2021
Gain Therapeutics, Inc. IPO completed
IPO completed detected for ticker Nasdaq:GANX in a 424B4 filed on 22 March, 2021.
This is the initial public offering of shares of common stock of Gain Therapeutics, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Gain Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.Market Cap
$96.5M
View Company Details
$96.5M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.